Golden, CO, May 25, 2011 --(PR.com
)-- PharmaJet® today announced that Chairman, Heather Callender-Potters is an Ernst & Young Entrepreneur Of The Year® 2011 finalist. The Ernst & Young award program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Heather Callender-Potters was selected by a panel of independent judges. Award winners will be announced at a special gala event on Thursday, June 16th at the Seawell Ballroom in the Denver Center for the Performing Arts.
“I am honored to be among the finalists for the E&Y award and to share the PharmaJet® story of our innovative, needle-free injection device, optimized for safe vaccine delivery—the most effective form of preventative healthcare,” says Heather Callender-Potters, Chairman of PharmaJet®. “To be included with a group of entrepreneurs, who are each impressive within their industries, is inspiring. Success is not only about passion and vision, but it is also about commitment. This strengthens my own commitment to PharmaJet’s global plans and our vision, and allows me to reconfirm publicly my convictions about working tirelessly to accomplish them.”
The Ernst & Young Entrepreneur Of The Year Program celebrates its 25th anniversary this year. The program has expanded to recognize business leaders in more than 140 cities and more than 50 countries throughout the world.
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National Award. Award winners in several national categories, as well as the Entrepreneur Of The Year overall National Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 12, 2011. The awards are the culminating event of the Ernst & Young Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies, which will be held November 9–13, 2011.
About PharmaJet® Inc. and Needle‐free Injection Technology:
PharmaJet’s needle‐free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet® injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating needle‐stick risk and the burden of sharps waste management. Further benefits of PharmaJet® injectors include the potential for dose‐sparing of vaccines, reducing the overall cost of vaccine delivery. For more information on PharmaJet’s needle‐free injection technology, please visit http://www.pharmajet.com.
About Ernst & Young Entrepreneur Of The Year®
Ernst & Young Entrepreneur Of The Year® is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 140 cities in more than 50 countries.
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are pleased to have the Ewing Marion Kauffman Foundation as a national sponsor. In the Mountain Desert region sponsors include Faegre & Benson, Clifton Gunderson, ADP, Scherzer International, The Denver Business Journal and JohnstonWells Public Relations.
About Ernst & Young
Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 141,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.
Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US. For more information about our organization, please visit www.ey.com.